Because of its importance in acute inflammation, several groups have developed inhibitory antibodies [12–14] and synthetic small molecule inhibitors of MIF [15–18], and shown that they can prevent morbidity and mortality associated with endotoxemia and sepsis [16, 18–20]. Here, MIF is linked to Sepsis.